gemzar
eli lilly and company (nz) limited - gemcitabine hydrochloride 228mg equivalent to 200 mg gemcitabine free base - powder for infusion - 200 mg - active: gemcitabine hydrochloride 228mg equivalent to 200 mg gemcitabine free base excipient: hydrochloric acid mannitol nitrogen sodium acetate sodium hydroxide
macugen
pfizer new zealand limited - pegaptanib sodium 3.47 mg/ml - solution for injection - 300 mcg/dose - active: pegaptanib sodium 3.47 mg/ml excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate sodium chloride water for injection
primene
baxter healthcare ltd - alanine 8 g/l; ; ; ; arginine 8.4 g/l; ; ; ; aspartic acid 6 g/l; ; ; cysteine 1.89 g/l; ; glutamic acid 10 g/l; ; glycine 4 g/l; ; ; histidine 3.8 g/l; ; ; isoleucine 6.7 g/l; ; ; ; ; ; leucine 10 g/l; ; ; ; ; lysine 11 g/l; methionine 2.4 g/l; ; ; ornithine hydrochloride 3.18 g/l; ; phenylalanine 4.2 g/l; ; ; ; ; proline 3 g/l; ; ; serine 4 g/l; ; ; taurine 0.6 g/l; ; threonine 3.7 g/l; ; ; ; tryptophan 2 g/l; ; ; ; tyrosine 0.45 g/l; ; ; valine 7.6 g/l; ; - solution for infusion - 10 % - active: alanine 8 g/l arginine 8.4 g/l aspartic acid 6 g/l cysteine 1.89 g/l glutamic acid 10 g/l glycine 4 g/l histidine 3.8 g/l isoleucine 6.7 g/l leucine 10 g/l lysine 11 g/l methionine 2.4 g/l ornithine hydrochloride 3.18 g/l phenylalanine 4.2 g/l proline 3 g/l serine 4 g/l taurine 0.6 g/l threonine 3.7 g/l tryptophan 2 g/l tyrosine 0.45 g/l valine 7.6 g/l excipient: malic acid water for injection - primene 10% amino acids iv infusion solution is indicated in infants and neonates at term or premature for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral solution.
vamin 14 with electrolytes
fresenius kabi new zealand limited - alanine 12 g/l; ; ; ; arginine 8.4 g/l (l-arginine); ; ; aspartic acid 2.5 g/l (l-aspartic acid); ; ; calcium gluconate monohydrate 2.24 g/l; ; cysteine 0.42 g/l (as l-cysteine hydrochloride); glutamic acid 4.2 g/l (l-glutamic acid); ; ; glycine 5.9 g/l (as aminoacetic acid); ; ; histidine 5.1 g/l (l-histidine); ; ; isoleucine 4.2 g/l (l-isoleucine); ; ; ; leucine 5.9 g/l (l-leucine); ; ; ; lysine hydrochloride 6.8 g/l; ; ; ; magnesium sulfate heptahydrate 1.97 g/l; methionine 4.2 g/l (l-methionine); ; ; phenylalanine 5.9 g/l (l-phenylalanine); ; ; ; potassium chloride 3.73 g/l; proline 5.1 g/l (l-proline); ; serine 3.4 g/l (l-serine); ; ; ; ; sodium acetate trihydrate 13.6 g/l; ; ; threonine 4.2 g/l (l-threonine); ; ; ; tryptophan 1.4 g/l (l-tryptophan); ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine); ; - solution for infusion - active: alanine 12 g/l arginine 8.4 g/l (l-arginine) aspartic acid 2.5 g/l (l-aspartic acid) calcium gluconate monohydrate 2.24 g/l cysteine 0.42 g/l (as l-cysteine hydrochloride) glutamic acid 4.2 g/l (l-glutamic acid) glycine 5.9 g/l (as aminoacetic acid) histidine 5.1 g/l (l-histidine) isoleucine 4.2 g/l (l-isoleucine) leucine 5.9 g/l (l-leucine) lysine hydrochloride 6.8 g/l magnesium sulfate heptahydrate 1.97 g/l methionine 4.2 g/l (l-methionine) phenylalanine 5.9 g/l (l-phenylalanine) potassium chloride 3.73 g/l proline 5.1 g/l (l-proline) serine 3.4 g/l (l-serine) sodium acetate trihydrate 13.6 g/l threonine 4.2 g/l (l-threonine) tryptophan 1.4 g/l (l-tryptophan) tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine) excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally
visudyne
link pharmaceuticals ltd - verteporfin 15mg - powder for infusion - 15 mg - active: verteporfin 15mg excipient: ascorbyl palmitate butylated hydroxytoluene dimyristoylphosphatidylcholine lactose monohydrate phosphatidylglycerols - visudyne is indicated for the treatment of patients with predominately classic or occult subfoveal choroidal neovascularisation due to age-related macular degeneration (amd), or with subfoveal choroidal neovascularisation caused by other macular diseases.
astepro
viatris limited - azelastine hydrochloride 1.5 mg/ml - nasal spray solution - 0.15% w/v - active: azelastine hydrochloride 1.5 mg/ml excipient: benzalkonium chloride disodium edetate hypromellose purified water sodium citrate sorbitol sucralose - for the treatment of hay-fever symptoms caused by seasonal and non-seasonal allergies including pollen, house mites and pet hair
dymista
viatris limited - azelastine hydrochloride 1 mg/g ((137 micrograms/spray)); fluticasone propionate 0.365 mg/g ((50 micrograms/spray)) - nasal spray suspension - active: azelastine hydrochloride 1 mg/g ((137 micrograms/spray)) fluticasone propionate 0.365 mg/g ((50 micrograms/spray)) excipient: benzalkonium chloride disodium edetate glycerol microcrystalline cellulose and carmellose sodium nitrogen phenethyl alcohol polysorbate 80 purified water - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.
gaviscon pregnancy
reckitt benckiser (new zealand) limited - potassium bicarbonate 20 mg/ml; sodium alginate 100 mg/ml - oral solution - active: potassium bicarbonate 20 mg/ml sodium alginate 100 mg/ml excipient: calcium carbonate carbomer 974 methyl hydroxybenzoate peppermint flavour phl-003452 propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - gaviscon pregnancy brings fast, soothing and long lasting relief from the pain and discomfort of heartburn (gastric reflux) and indigestion. (label claim).
alecensa
roche products (nz) ltd - alectinib hydrochloride 161.33mg equivalent to alectinib 150mg - capsule - 150 mg - active: alectinib hydrochloride 161.33mg equivalent to alectinib 150mg excipient: black ink (alecensa) carmellose calcium carnauba wax carrageenan hyprolose hypromellose lactose monohydrate magnesium stearate maize starch potassium chloride sodium laurilsulfate titanium dioxide - alecensa is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive, locally advanced or metastatic non-small cell lung cancer (nsclc).
scenesse
dor pharmaceutical services ltd., israel - afamelanotide as acetate - implant - afamelanotide as acetate 16 mg - afamelanotide - scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).